About us
Overview
Our strategy
Our leadership
How we’re funded
Our history
What we do
Overview
Our science
Therapeutics
Diagnostics development
Partnering with us
Funding, projects and partnerships
Available technologies
LifeArc Ventures
IP management and tech transfer
Policy and public affairs
Translational Challenges
Overview
Motor Neuron Disease
Chronic Respiratory Infection
Global Health
Antimicrobial Resistance
Neglected Tropical Diseases
Emerging Viral Threats
Rare Disease
Childhood Cancer
News and events
News
Events
Careers
Overview
Benefits and rewards
Early careers
Current vacancies
Contact us
Search
Toggle Menu
Search
Search
Search
Refine results
Content Type
Careers
Case Studies
Funding Calls
Other Technologies
Pages
People
Posts
Projects
Publications
Therapeutics
Topic
Company updates
Motor neuron disease
Chronic respiratory infection
Global health
Rare disease
Childhood cancer
Neurodegeneration
Policy and public affairs
Technology transfer
Our science
Ventures
Privacy policy
Publication
18 March 2024
Read more
: Privacy policy
Kymab and LifeArc enter strategic partnership to discover new medicines using Kymab’s IntelliSelect® technologies
Post
24 June 2019
Read more
: Kymab and LifeArc enter strategic partnership to discover new medicines using Kymab’s IntelliSelect® technologies
KQ Labs opens accelerator programme and announces LifeArc as a strategic partner
Post
6 July 2020
Read more
: KQ Labs opens accelerator programme and announces LifeArc as a strategic partner
KQ Labs opens applications for health start-ups for its annual accelerator programme
Post
17 May 2021
Read more
: KQ Labs opens applications for health start-ups for its annual accelerator programme
Biocartis expands collaboration with LifeArc
Post
1 September 2020
Read more
: Biocartis expands collaboration with LifeArc
Innovative gene therapy programme paves the way for new treatments for neurodegenerative diseases
Post
29 July 2021
Read more
: Innovative gene therapy programme paves the way for new treatments for neurodegenerative diseases
SpringWorks Therapeutics launched to progress investigational therapies for patients with unmet medical needs
Post
25 September 2017
Read more
: SpringWorks Therapeutics launched to progress investigational therapies for patients with unmet medical needs
LifeArc marks Rare Disease Day 2020 with a call for more translational research
Post
28 February 2020
Read more
: LifeArc marks Rare Disease Day 2020 with a call for more translational research
Celebrating the International Day of Women and Girls in Science
Post
11 February 2020
Read more
: Celebrating the International Day of Women and Girls in Science
LifeArc launches Technology Transfer Fellowships
Post
17 December 2018
Read more
: LifeArc launches Technology Transfer Fellowships
LifeArc portfolio company Ducentis BioTherapeutics acquired by Arcutis Biotherapeutics for up to $400 million
Post
8 September 2022
Read more
: LifeArc portfolio company Ducentis BioTherapeutics acquired by Arcutis Biotherapeutics for up to $400 million
LifeArc Seed Fund makes £1.5million investment in Caldan Therapeutics to develop novel treatments for metabolic diseases
Post
29 August 2019
Read more
: LifeArc Seed Fund makes £1.5million investment in Caldan Therapeutics to develop novel treatments for metabolic diseases
1
2
3
…
10
Next Page
Close Modal
WordPress development by
Andy White
using
PorterWP